Please enable JavaScript to continue using this application.

Compare $BMRN vs $MDGL | Chartloom

Compare

$BMRN vs $MDGL

BioMarin Pharmaceutical Inc · Madrigal Pharmaceuticals Inc

BMRN

BioMarin Pharmaceutical Inc

MDGL

Madrigal Pharmaceuticals Inc

Compare $BMRN vs $MDGL

Comparing BioMarin Pharmaceutical Inc and Madrigal Pharmaceuticals Inc

BMRNBioMarin Pharmaceutical Inc

MDGLMadrigal Pharmaceuticals Inc

BMRNBioMarin Pharmaceutical Inc

Market cap

$10.59B

P/E (TTM)

146.03x

Forward P/E (NTM)

12.82x

Forward P/S (NTM)

2.41x

Rev growth (TTM)

11.2%

YTD performance

-7.8%

52W performance

0.2%

FCF yield

6.8%

MDGLMadrigal Pharmaceuticals Inc

Market cap

$10.88B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.94x

Rev growth (TTM)

149.0%

YTD performance

-20.6%

52W performance

8.0%

FCF yield

-1.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BMRN

MDGL

Detailed metrics comparison

BMRN

BioMarin Pharmaceutical Inc

MDGL

Madrigal Pharmaceuticals Inc

Market Cap

BMRN$10.59B

MDGL$10.88B

Enterprise Value

BMRN$13.90B

MDGL$10.93B

Price

BMRN$54.80

MDGL$471.75

P/E Ratio

BMRN146.03x

MDGLN/A

P/S Ratio

BMRN3.11x

MDGL8.47x

EV/Sales

BMRN4.08x

MDGL8.51x

EV/EBITDA

BMRN16.77x

MDGL699.23x

P/B Ratio

BMRN1.75x

MDGL22.03x

P/FCF Ratio

BMRN14.61x

MDGLN/A

EV/FCF

BMRN19.17x

MDGL-52.02x

PEG Ratio

BMRN4.10x

MDGLN/A

Forward P/E (NTM)

BMRN12.82x

MDGLN/A

Forward P/S (NTM)

BMRN2.41x

MDGL5.94x

Revenue (TTM)

BMRN$3.41B

MDGL$1.28B

Revenue Growth (YoY)

BMRN11.2%

MDGL149.0%

Forward Rev Growth

BMRN14.5%

MDGL41.6%

Gross Margin (TTM)

BMRN79.6%

MDGL91.5%

Operating Margin (TTM)

BMRN4.4%

MDGL0.0%

EBITDA Margin (TTM)

BMRN24.3%

MDGL-25.0%

Net Margin (TTM)

BMRN2.1%

MDGL-25.3%

FCF Margin (TTM)

BMRN21.3%

MDGL-16.4%

Net Income (TTM)

BMRN$73M

MDGL$-325M

FCF (TTM)

BMRN$725M

MDGL$-210M

EPS (TTM)

BMRN$0.38

MDGL-$11.15

ROE (TTM)

BMRN1.2%

MDGL-5665.0%

ROA (TTM)

BMRN82.0%

MDGL-2553.0%

ROIC (TTM)

BMRN93.0%

MDGL-3556.0%

Cash

BMRN$874M

MDGL$293M

Debt

BMRN$4.19B

MDGL$341M

Net Cash/Debt

BMRN$-3.31B

MDGL$-48M

Current Ratio (TTM)

BMRN2.39x

MDGL3.20x

Quick Ratio (TTM)

BMRN1.16x

MDGL2.76x

Debt/Equity (TTM)

BMRN0.66x

MDGL0.65x

Debt/Assets (TTM)

BMRN0.0%

MDGL0.0%

Interest Coverage (TTM)

BMRNN/A

MDGLN/A

Net Debt/EBITDA (TTM)

BMRN0.00x

MDGL0.00x

Beta

BMRN0.23

MDGL-1.08

52W Performance

BMRN0.2%

MDGL8.0%

YTD Performance

BMRN-7.8%

MDGL-20.6%

% from 52W High

BMRN-22.8%

MDGL-23.3%

% from 52W Low

BMRN11.2%

MDGL19.9%

Asset Turnover (TTM)

BMRN0.38x

MDGL1.01x

FCF Yield (TTM)

BMRN6.8%

MDGL-1.9%

Earnings Yield (TTM)

BMRN0.7%

MDGL-3.0%

Dividend Yield (TTM)

BMRNN/A

MDGLN/A

Rule of 40

BMRN32.5

MDGL132.7

EV/GP/RG

BMRN0.18

MDGL0.21

Ticker research

View BMRN research View MDGL research

Metric	BMRN BioMarin Pharmaceutical Inc	MDGL Madrigal Pharmaceuticals Inc
Market & Valuation
Market Cap	$10.59B	$10.88B
Enterprise Value	$13.90B	$10.93B
Price	$54.80	$471.75
P/E Ratio	146.03x	N/A
P/S Ratio	3.11x	8.47x
EV/Sales	4.08x	8.51x
EV/EBITDA	16.77x	699.23x
P/B Ratio	1.75x	22.03x
P/FCF Ratio	14.61x	N/A
EV/FCF	19.17x	-52.02x
PEG Ratio	4.10x	N/A
Forward P/E (NTM)	12.82x	N/A
Forward P/S (NTM)	2.41x	5.94x
Revenue & Growth
Revenue (TTM)	$3.41B	$1.28B
Revenue Growth (YoY)	11.2%	149.0%
Forward Rev Growth	14.5%	41.6%
Profitability
Gross Margin (TTM)	79.6%	91.5%
Operating Margin (TTM)	4.4%	0.0%
EBITDA Margin (TTM)	24.3%	-25.0%
Net Margin (TTM)	2.1%	-25.3%
FCF Margin (TTM)	21.3%	-16.4%
Net Income (TTM)	$73M	$-325M
FCF (TTM)	$725M	$-210M
EPS (TTM)	$0.38	-$11.15
ROE (TTM)	1.2%	-5665.0%
ROA (TTM)	82.0%	-2553.0%
ROIC (TTM)	93.0%	-3556.0%
Financial Health
Cash	$874M	$293M
Debt	$4.19B	$341M
Net Cash/Debt	$-3.31B	$-48M
Current Ratio (TTM)	2.39x	3.20x
Quick Ratio (TTM)	1.16x	2.76x
Debt/Equity (TTM)	0.66x	0.65x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	-1.08
52W Performance	0.2%	8.0%
YTD Performance	-7.8%	-20.6%
% from 52W High	-22.8%	-23.3%
% from 52W Low	11.2%	19.9%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	1.01x
FCF Yield (TTM)	6.8%	-1.9%
Earnings Yield (TTM)	0.7%	-3.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	32.5	132.7
EV/GP/RG	0.18	0.21
Ticker research	View BMRN research	View MDGL research

Valuation

P/E Ratio

BMRN

146.03x

P/S Ratio

BMRN

3.11x

MDGL

8.47x

EV/FCF

MDGL

-52.02x

BMRN

19.17x

Growth & revenue

Revenue Growth TTM

MDGL

149.0%

BMRN

11.2%

Forward Revenue Growth

MDGL

41.6%

BMRN

14.5%

Profitability & performance

Gross Margin

MDGL

91.5%

BMRN

79.6%

ROE

BMRN

1.2%

MDGL

-5665.0%

FCF Yield %

BMRN

6.8%

MDGL

-1.9%

52-Week Performance

MDGL

8.0%

BMRN

0.2%

Detailed metrics comparison

BMRN

BioMarin Pharmaceutical Inc

MDGL

Madrigal Pharmaceuticals Inc

Market Cap

BMRN$10.59B

MDGL$10.88B

Enterprise Value

BMRN$13.90B

MDGL$10.93B

Price

BMRN$54.80

MDGL$471.75

P/E Ratio

BMRN146.03x

MDGLN/A

P/S Ratio

BMRN3.11x

MDGL8.47x

EV/Sales

BMRN4.08x

MDGL8.51x

EV/EBITDA

BMRN16.77x

MDGL699.23x

P/B Ratio

BMRN1.75x

MDGL22.03x

P/FCF Ratio

BMRN14.61x

MDGLN/A

EV/FCF

BMRN19.17x

MDGL-52.02x

PEG Ratio

BMRN4.10x

MDGLN/A

Forward P/E (NTM)

BMRN12.82x

MDGLN/A

Forward P/S (NTM)

BMRN2.41x

MDGL5.94x

Revenue (TTM)

BMRN$3.41B

MDGL$1.28B

Revenue Growth (YoY)

BMRN11.2%

MDGL149.0%

Forward Rev Growth

BMRN14.5%

MDGL41.6%

Gross Margin (TTM)

BMRN79.6%

MDGL91.5%

Operating Margin (TTM)

BMRN4.4%

MDGL0.0%

EBITDA Margin (TTM)

BMRN24.3%

MDGL-25.0%

Net Margin (TTM)

BMRN2.1%

MDGL-25.3%

FCF Margin (TTM)

BMRN21.3%

MDGL-16.4%

Net Income (TTM)

BMRN$73M

MDGL$-325M

FCF (TTM)

BMRN$725M

MDGL$-210M

EPS (TTM)

BMRN$0.38

MDGL-$11.15

ROE (TTM)

BMRN1.2%

MDGL-5665.0%

ROA (TTM)

BMRN82.0%

MDGL-2553.0%

ROIC (TTM)

BMRN93.0%

MDGL-3556.0%

Cash

BMRN$874M

MDGL$293M

Debt

BMRN$4.19B

MDGL$341M

Net Cash/Debt

BMRN$-3.31B

MDGL$-48M

Current Ratio (TTM)

BMRN2.39x

MDGL3.20x

Quick Ratio (TTM)

BMRN1.16x

MDGL2.76x

Debt/Equity (TTM)

BMRN0.66x

MDGL0.65x

Debt/Assets (TTM)

BMRN0.0%

MDGL0.0%

Interest Coverage (TTM)

BMRNN/A

MDGLN/A

Net Debt/EBITDA (TTM)

BMRN0.00x

MDGL0.00x

Beta

BMRN0.23

MDGL-1.08

52W Performance

BMRN0.2%

MDGL8.0%

YTD Performance

BMRN-7.8%

MDGL-20.6%

% from 52W High

BMRN-22.8%

MDGL-23.3%

% from 52W Low

BMRN11.2%

MDGL19.9%

Asset Turnover (TTM)

BMRN0.38x

MDGL1.01x

FCF Yield (TTM)

BMRN6.8%

MDGL-1.9%

Earnings Yield (TTM)

BMRN0.7%

MDGL-3.0%

Dividend Yield (TTM)

BMRNN/A

MDGLN/A

Rule of 40

BMRN32.5

MDGL132.7

EV/GP/RG

BMRN0.18

MDGL0.21

Ticker research

View BMRN research View MDGL research

Metric	BMRN BioMarin Pharmaceutical Inc	MDGL Madrigal Pharmaceuticals Inc
Market & Valuation
Market Cap	$10.59B	$10.88B
Enterprise Value	$13.90B	$10.93B
Price	$54.80	$471.75
P/E Ratio	146.03x	N/A
P/S Ratio	3.11x	8.47x
EV/Sales	4.08x	8.51x
EV/EBITDA	16.77x	699.23x
P/B Ratio	1.75x	22.03x
P/FCF Ratio	14.61x	N/A
EV/FCF	19.17x	-52.02x
PEG Ratio	4.10x	N/A
Forward P/E (NTM)	12.82x	N/A
Forward P/S (NTM)	2.41x	5.94x
Revenue & Growth
Revenue (TTM)	$3.41B	$1.28B
Revenue Growth (YoY)	11.2%	149.0%
Forward Rev Growth	14.5%	41.6%
Profitability
Gross Margin (TTM)	79.6%	91.5%
Operating Margin (TTM)	4.4%	0.0%
EBITDA Margin (TTM)	24.3%	-25.0%
Net Margin (TTM)	2.1%	-25.3%
FCF Margin (TTM)	21.3%	-16.4%
Net Income (TTM)	$73M	$-325M
FCF (TTM)	$725M	$-210M
EPS (TTM)	$0.38	-$11.15
ROE (TTM)	1.2%	-5665.0%
ROA (TTM)	82.0%	-2553.0%
ROIC (TTM)	93.0%	-3556.0%
Financial Health
Cash	$874M	$293M
Debt	$4.19B	$341M
Net Cash/Debt	$-3.31B	$-48M
Current Ratio (TTM)	2.39x	3.20x
Quick Ratio (TTM)	1.16x	2.76x
Debt/Equity (TTM)	0.66x	0.65x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	-1.08
52W Performance	0.2%	8.0%
YTD Performance	-7.8%	-20.6%
% from 52W High	-22.8%	-23.3%
% from 52W Low	11.2%	19.9%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	1.01x
FCF Yield (TTM)	6.8%	-1.9%
Earnings Yield (TTM)	0.7%	-3.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	32.5	132.7
EV/GP/RG	0.18	0.21
Ticker research	View BMRN research	View MDGL research